JFA
DMK

JNBA Financial Advisors’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

JNBA Financial Advisors’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-12
Closed -$3K – 1424
2016
Q3 		$3K Buy
+12
New +$2.49K ﹤0.01% 1376

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SGS
Sterling Global Strategies Carlsbad, California $18M AUM 11.58% 1-Year Est. Return

JNBA Financial Advisors's DMK Position: Q4 2016 in Review

JNBA Financial Advisors sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2016, closing a stake of 12 shares — an estimated $3K sold.

JNBA Financial Advisors first reported a position in DMK in Q3 2016 and held it in 1 quarter. The position peaked at $3K in Q3 2016. 35 funds tracked by Wall St. Rank hold DMK as of Q4 2016.

  • JNBA Financial Advisors reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2016 after selling out during the quarter.
  • JNBA Financial Advisors sold 12 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2016, an estimated $3K.
  • JNBA Financial Advisors first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q3 2016 and held it in 1 quarter.
  • JNBA Financial Advisors's DMK Pharmaceuticals Corporation Common Stock position peaked at $3K in Q3 2016.
  • 35 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2016.

Based on JNBA Financial Advisors's 13F filing for Q4 2016, filed 3 Feb 2017.